|Year : 2016 | Volume
| Issue : 3 | Page : 362-368
Oral verrucous hyperplasia versus oral verrucous carcinoma: A clinicopathologic dilemma revisited using p53 as immunohistochemical marker
Preeti Sharma1, Vijay Wadhwan1, Pooja Aggarwal1, Anamika Sharma2
1 Department of Oral Pathology and Microbiology, Subharti Dental College, Meerut, Uttar Pradesh, India
2 Department of Periodontics, Subharti Dental College, Meerut, Uttar Pradesh, India
|Date of Submission||26-Jul-2016|
|Date of Acceptance||03-Aug-2016|
|Date of Web Publication||21-Sep-2016|
BH-15, Pallavpuram, Phase - I, Meerut - 250 110, Uttar Pradesh
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Background: Oral verrucous hyperplasia (OVH) and oral verrucous carcinoma (OVC) are two distinct clinicopathologic verrucous lesions. However, the distinction between the two lesions still remains enigmatic. It is almost impossible to distinguish them clinically. Thus, the final diagnosis rests on the histopathological characteristics of both lesions, being distinguished from each other by an exophytic and endophytic growth pattern, respectively.
Methods: This institutional study was planned to review retrospectively two series of patients with histologic diagnoses of VH (n = 27) and VC (n = 27) to investigate their clinicopathological features and to analyze the role of immunohistochemical (IHC) marker p53 protein in distinguishing between the two verrucous lesions. The biopsies of the histopathologically diagnosed cases spanning last 10 years were retrieved from the archives of the Oral Pathology department of the institution. Clinical data were tabulated and analyzed for age, gender, site and tobacco habits. IHC staining was done on all the samples using p53 antibody.
Results : Applying Chi-square test, the buccal mucosa was the most common affected site and tobacco chewing was more prevalent habit in both these lesions (P > 0.05). While the elderly males (>60 years) were the most commonly affected group in VC, a relatively younger age group of males (30-39 years) was more commonly affected in VH (P < 0.05). IHC staining with p53 antibody did not show any significant difference between these two verrucous lesions (P > 0.05) .
Conclusion: VH and VC are closely related lesions distinguished by an adequate biopsy sample.
Keywords: p53 protein, tobacco chewing, verrucous carcinoma, verrucous hyperplasia
|How to cite this article:|
Sharma P, Wadhwan V, Aggarwal P, Sharma A. Oral verrucous hyperplasia versus oral verrucous carcinoma: A clinicopathologic dilemma revisited using p53 as immunohistochemical marker. J Oral Maxillofac Pathol 2016;20:362-8
|How to cite this URL:|
Sharma P, Wadhwan V, Aggarwal P, Sharma A. Oral verrucous hyperplasia versus oral verrucous carcinoma: A clinicopathologic dilemma revisited using p53 as immunohistochemical marker. J Oral Maxillofac Pathol [serial online] 2016 [cited 2017 May 29];20:362-8. Available from: http://www.jomfp.in/text.asp?2016/20/3/362/190902
| Introduction|| |
Oral verrucous hyperplasia (OVH) may be a precursor lesion of oral verrucous carcinoma (OVC) and it resembles oral VC both clinically and histopathologically.  OVC is a rare variant of oral squamous cell carcinoma (OSCC), first described by Ackermann, and henceforth also known as Ackermann's tumor.  Despite differences, a close relationship also exists between VC and OSCC. VH and VC often coexist with dysplasia and OSCC, and VH and VC have been reported to progress into OSCC. , OVC has unique histopathologic features and it is extremely challenging to diagnose it accurately. For correct evaluation of these two lesions, an adequate biopsy sample is of utmost importance along with an interaction between the clinician and the pathologist. In fact, some studies have shown that it took an average of three to four biopsies before a correct diagnosis of OVH or OVC could be made. , Shear and Pindborg  described the histopathological differences to differentiate between these two verrucous lesions. The hyperplastic epithelium was superficial to adjacent normal epithelium in VH; however, in VC, there was a pushing-border invasion of the hyperplastic epithelium into the underlying connective tissue. Nevertheless, differential diagnosis of these verrucous lesions remains an enigma for the histopathologists either because of the lack of adjacent normal epithelium when a biopsy is performed or because of the improper orientation of the specimen.
p53 is a tumor suppressor gene which is considered as the guardian of the genome. The loss of p53 function early in the carcinogenic process may contribute to the increase in the genetically altered cells resulting from exposure to carcinogens.  Various immunohistochemical (IHC) studies have exhibited p53 staining in oral premalignant lesions and thus p53 aberration is a common early event in oral carcinogenesis. ,, Numerous studies have been performed on the biopsies of OSCC demonstrating overexpression of p53 protein. , To date, very few studies of the p53 protein expression have been performed simultaneously on VH and VC, to help in differentiating the two lesions. Therefore, we planned this institution-based retrospective study to analyze the significant clinicopathological differences between these two oral verrucous lesions. In addition, the objective of the study was to use an IHC technique to examine the expression of p53 protein in oral VC and oral VH biopsies, thus assessing its role in differentiating oral VH from oral VC histopathologically.
| Materials and methods|| |
The present study was a retrospective study where the clinical details of the patients such as age, sex, habits, site of the lesion, clinical diagnosis and histopathology of the lesion were retrieved and recorded from the archives of the oral and maxillofacial pathology department of the institution over a span of 10 years (from January 1, 2004 to May 31, 2014). After obtaining formalin-fixed, paraffin-embedded specimens, serial sectioning was done and the first section was stained with hematoxylin and eosin for histopathological assessment to reach a consensus with the original diagnosis. The diagnoses of oral VH and oral VC were based on the histological examination of hematoxylin- and eosin-stained tissue sections.
The histological criteria for the diagnosis of oral VC included: (a) Epithelial overgrowth with wide and elongated rete ridges exhibiting a pushing-border invasion into the underlying connective tissue, (b) papillary or verruciform epithelial projections with abundant parakeratin production and (c) the lesional epithelial cells showing a normal maturation pattern with no significant degree of cellular atypia  [Figure 1].
|Figure 1: Photomicrograph of oral verrucous carcinoma. Tumor growth is mainly endophytic with broad pushing margins relative to the normal location of the oral epithelium (H&E stain, ×40)|
Click here to view
While the histological criteria employed for the diagnosis of oral VH were: (a) Epithelial hyperplasia with parakeratosis or hyperkeratosis and verrucous surface, (b) no invasion of the hyperplastic epithelium into the lamina propria compared with adjacent normal mucosal epithelium  [Figure 2].
|Figure 2: Oral verrucous hyperplasia shows both sharp and blunt verrucous projections with adjacent normal epithelium showing rete ridges at the same level (H&E stain, ×100)|
Click here to view
The detailed demographic and clinical data of oral VH and VC patients were retrieved from the clinical records of the patients and were analyzed in a tabulated form as listed in [Table 1]. Clinical details recorded from the patient's records were age, sex, anatomical site, clinical features, clinical diagnosis and tobacco as well as alcohol habits. Details of the duration and frequency of habit could not be recorded because of the retrospective nature of the study. Histopathological features of oral VH were recorded in a tabulated form listed under the following headings: The verrucous projections, the presence of keratinization (ortho and parakeratinization); degrees of epithelial dysplasia; the thickness of stratum spinosum; the width of the rete ridges.
|Table 1: Comparison of clinical and demographic data of OVH and OVC patients (from 2004-2014) over a span of 10 years |
Click here to view
Serial sections of 4-µm thickness were cut from all the retrieved samples and IHC staining was performed using a peroxidase-labeled streptavidin-biotin technique. The tissue sections were heated in a plastic slide holder (DAKO, Copenhagen, Denmark) containing 0.01 M citrate buffer in a microwave oven for 12 min (3 min for each cycle) for antigen retrieval. Next, the sections were treated with 3% H 2 O 2 in methanol for 10 min to quench endogenous peroxidase activity. After washing in 10 mM Tris-buffered saline (TBS), pH 7.6, sections were incubated with 10% normal goat serum to block nonspecific binding. Sections were then incubated for one hour, with the primary antibody, i.e. p53 protein. Again, sections were washed in TBS and treated with a mixture of biotinylated goat anti-mouse immunoglobulin G (Ig G) and biotinylated goat anti-rabbit IgG, and subsequently, with the streptavidin-peroxidase conjugate. The 0.02% diaminobenzidine hydrochloride containing 0.03% H 2 O 2 was used as a chromogen to visualize the peroxidase activity. The sections were counterstained with Harris' hematoxylin and mounted in disterene dibutylphthalate xylene (DPX). Tissue sections of OSCC were taken as positive controls and were considered positive for p53 only when distinct nuclear staining was identified, while gingivectomy tissues, obtained after patient's written consent, served as the negative control, which were provided by the department of periodontology of the institution.
The positive samples for p53 protein were determined by examining sections at ×400. A specimen with ≥10% positive nuclei by counting all basal and parabasal cells in the lesion was defined as positive similar to the criteria by Wong et al.  According to this criteria, cells of tumor nests were counted along with the number of p53 immunoreactive cells in OSCC samples, thus calculating the aggregate positive cells.
The detailed comprehensive data of clinical details of both series of patients as well as the comparative positivity of p53 protein in both series of patients were analyzed with Chi-square test.
| Results|| |
This study comprehensively analyzed the clinical records of the histopathologically diagnosed cases of OVC and OVH [Table 1]. The evaluation of oral VH patients showed a preponderance of the relatively younger age group, i.e., in the 3 rd decade followed closely by patients in the 5 th and 6 th decade. The mean age of our patients with OVC was significantly older than that of patients with oral VH (P < 0.05) and the mean tumor size of oral VC lesions was significantly larger than that of oral VH lesions (P < 0.05). However, no significant differences in the other clinical parameters including the gender of the patient, lesion site and tobacco habits were found between the two series of patients.
On clinical examination, some lesions extended to adjacent sides, and the area most extensively involved was recorded. The buccal mucosa was the most frequently involved site observed predominantly in males in both the lesions and no significant difference was found between the two groups (P > 0.05). The gingiva and palate were the other common sites in VC while lower lip was the next most commonly involved site in VH.
Clinically, two patterns were observed in VH, namely, sharp and blunt. Both were observed in our patients. The sharp variety comprised long, narrow, heavily keratinized verrucous processes. The second variety was the blunt variety and it exhibited verrucous processes that were broader and flatter and not heavily keratinized. However, in both types, leukoplakic areas may also be a part of the lesion in the same patient. Histopathologically, both varieties were observed compatible with the clinical variations. The sharp variety of VH showed long and narrow verrucous projections which were heavily keratinized [Figure 3]. Shorter and broader exophytic projections which were not heavily keratinized were observed in the blunt pattern of VH [Figure 4]. Hyperorthokeratosis was predominantly seen in the sharp variety whereas the blunt pattern exhibited mostly parakeratosis. In most of the cases, epithelial hyperplasia was observed as an increase in the thickness of stratum spinosum [Table 2]. When the thickness of the epithelium was normal but showed verrucous projections, it was reported as VH. In the majority of VH cases, rete ridges were broad and blunt [Table 2].
|Figure 3: Photomicrograph of a verrucous hyperplasia. The verrucous growth is exophytic with sharp projections (H&E stain, ×100)|
Click here to view
|Figure 4: Photomicrograph of a verrucous hyperplasia. The verrucous growth is exophytic with blunt projections (H&E stain, ×100)|
Click here to view
Dense and diffusely spread chronic inflammatory cell infiltration was present in the lamina propria in most of the cases of VH and VC, comprising mainly of lymphocytes, plasma cells and histiocytes. Epithelial dysplasia was a more prominent feature in VH and was graded ranging between mild and severe [Table 3].
|Table 3: Comparison of histologic features of epithelial dysplasia and p53 immunoreactivity between OVH and OVC |
Click here to view
No positive staining for p53 protein was observed in control normal gingival epithelium. Distributions of the immunostaining positive cells were similar for both OVC [Figure 5]a and b and OVH [Figure 6]a and b samples. The positive-staining cells were mainly located in the basal and parabasal layers for the p53 protein. Few sections also showed irregular moderate staining within the basal and parabasal layers but with ≥25% positive cells. No significant association of IHC marker in OVC or OVH samples with patient's age, lesion location, tumor size and oral habits of the patient was found in the present study. There were no specimens that exhibited diffuse p53 immunoreactivity through all the layers of the epithelium. Eighteen specimens of OVH and 21 specimens of OVC defined as negative for p53 immunoreactivity showed either the complete absence of p53-reactive cells or only scattered, sparsely located p53-reactive cells in the basal cell layer. Comparative evaluation of the P53 stained sections in both groups was done with the application of Chi-square test. However, no statistical significance was found between the two verrucous lesions for p53 immunoreactivity (P > 0.05) [Table 3].
|Figure 5: (a) Photomicrograph of oral verrucous carcinoma showing P53 positivity (IHC stain, ×100). (b) Uniform p53 positivity in basal and parabasal layers of oral verrucous carcinoma. Intensive nuclear staining extends 3-10 cells above the basal cells in focal areas (IHC stain, ×400)|
Click here to view
|Figure 6: (a) Continuous p53 positivity observed in oral verrucous hyperplasia in basal and parabasal layers (IHC stain, ×100). (b) Distribution of p53 protein in basal and parabasal layers of oral verrucous hyperplasia (IHC stain, ×400)|
Click here to view
| Discussion|| |
Very few studies have addressed the clinicopathologic enigma surrounding the two verrucous lesions, i.e. VH and VC, especially in South-East Asia, particularly in India. Our observations reveal that it is almost impossible to distinguish the two lesions clinically. Thus, the histopathologic differences between the two lesions act as a benchmark to arrive at a confirmatory diagnosis.
Shear and Pindborg  defined OVH as a verrucous lesion in which the surface may be either sharp and heavily keratinized or blunt with a thin parakeratin layer. It is distinguishable from OVC only in biopsies taken at the margin of the lesion. In OVC, the verrucous projections are superficial but the broad rete ridges extend much deeper than adjacent normal epithelium, with a pushing invasive border. Research studies have proved OVH as a precursor or an intermediate stage of OVC or OSCC formation. ,
The mean age of our patients with oral VC was significantly older than that of patients with oral VH, similar to findings by other studies. , This suggests that oral VH may be a precursor lesion of oral VC.  Shear and Pindborg  also considered oral VH as a potentially precancerous lesion of oral VC. However, contrast observations were reported by other research studies where the elderly population was a more affected group in OVH. ,,
Analyzing the demographic data, we observed a higher male preponderance in both these verrucous lesions simulating observations by the other authors in Taiwanese and Chinese population. ,
In contrast, elderly females were more commonly affected according to published literature on multifocal oral verrucous leukoplakia which shows histologic features of VH. ,, Tobacco chewing was the predominant habit in VC as well as VH. In a study by Ghazali et al.,  on VH group, and Walvekar et al.,  on OVC, betel quid chewing was the most common habit with length of exposure to this habit reported from more than 10 years to more than 50 years. Nevertheless, cigarette smoking was more prevalent in Taiwan population  and Chinese cohorts.  In our study, the buccal mucosa was the most common site involved in both the lesions. However, these observations contrast with other research studies , where gingiva and alveolar mucosa are most frequently involved, followed in order by the buccal mucosa, tongue, floor of the mouth, lip and palate. Similar contrast findings were reported by Shear and Pindborg  on VH samples. The mean tumor size was larger in OVC when compared with OVH simulating the observations by Lin et al. 
Epithelial hyperplasia with no atypia was seen in 22.3% of the cases with broad and blunt rete ridges in VH. Epithelial dysplasia was a prominent feature in 77.7% of the OVH cases. Similar observations were recorded in another study. 
The p53 is not immunodetectable in normal epithelium; however, infrequently certain p53 gene mutations result in protein accumulation and hence become detectable. p53 mutation is not the only factor affecting p53 protein level. The immunoreactivity of p53 is also observed by the factors stabilizing p53 and the overexpression of p53 caused by DNA damage. ,
Klieb and Raphael  investigated the expression of p53 in 32 oral VCs and 28 oral VH samples. They observed a more diffuse expression of p53 protein in oral VCs than that in oral VH lesions and suggested that IHC markers may be relevant as a diagnostic adjunct in difficult cases. However, our study showed no significant difference in p53 protein expression between oral VH and oral VC samples. Chang et al.  found a consistent absence of p53 staining in their oral VC and oral VH samples. These differences can be attributed to using different samples, staining procedures and evaluation methods for the p53 protein.
As per the study by Lin et al.,  their study suggested the failure of using the panel of IHC markers and partially explained the abnormal epithelial overgrowth in oral VC and oral VH lesions to MDM2 overexpression-induced inactivation of p53 protein. Thus, it is proposed that an incisional biopsy with adequate depth and the adjacent normal mucosa may serve as the gold standard for conclusive diagnosis of these two verrucous lesions. Because the individual cells are not very dysplastic, the pathologist must evaluate the overall histomorphologic configuration of the lesion to arrive at an appropriate diagnosis. An adequate sampling is a must because as many as 20% of these lesions have a routine SCC developing concurrently within the VC.  The close similarity in the expression and distribution pattern of p53 in the present study indicates that oral VH and oral VC are intimately related lesions showing a nearly similar degree of gene alterations. Therefore, early treatment of oral VH is of utmost consideration to prevent its malignant transformation to oral VC.
The oral VH and oral VC are closely related lesions which cannot be diagnosed clinically. Therefore, the diagnosis of oral VH and oral VC must be established histopathologically. Accurate histopathologic diagnosis depends on an adequate depth of the biopsy specimen and the adjacent normal epithelium. The present study suggests the inability of IHC marker like p53 protein to distinguish between these two verrucous lesions. Furthermore, this study was a clinicopathological analysis of patients with oral verrucous lesions, i.e., OVH and OVC, wherein no significant difference was found in the clinical parameters such as site, sex and habits while tumor size and age showed a statistically significant difference. Therefore, more series of research need to be done and a larger panel of IHC markers should be analyzed to dissolve the dilemma in differentiating these two lesions histopathologically.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Zhu LK, Ding YW, Liu W, Zhou YM, Shi LJ, Zhou ZT. A clinicopathological study on verrucous hyperplasia and verrucous carcinoma of the oral mucosa. J Oral Pathol Med 2012;41:131-5.
Ackerman LV. Verrucous carcinoma of the oral cavity. Surgery 1948;23:670-8.
Shear M, Pindborg JJ. Verrucous hyperplasia of the oral mucosa. Cancer 1980;46:1855-62.
Poh CF, Zhang L, Lam WL, Zhang X, An D, Chau C, et al.
A high frequency of allelic loss in oral verrucous lesions may explain malignant risk. Lab Invest 2001;81:629-34.
Biller HF, Ogura JH, Bauer WC. Verrucous cancer of the larynx. Laryngoscope 1971;81:1323-9.
Jordan RC. Verrucous carcinoma of the mouth. J Can Dent Assoc 1995;61:797-801.
Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991;51(23 Pt 1):6304-11.
Ries JC, Schreiner D, Steininger H, Girod SC. p53 mutation and detection of p53 protein expression in oral leukoplakia and oral squamous cell carcinoma. Anticancer Res 1998;18:2031-6.
Regezi JA, Zarbo RJ, Regev E, Pisanty S, Silverman S, Gazit D. p53 protein expression in sequential biopsies of oral dysplasias and in situ
carcinomas. J Oral Pathol Med 1995;24:18-22.
Kerdpon D, Rich AM. Association of p53 expression with outcome of dysplastic oral lesion. J Dent Res 1996;75:332. [Abstract].
Wong YK, Liu TY, Chang KW, Lin SC, Chao TW, Li PL, et al.
p53 alterations in betel quid- and tobacco-associated oral squamous cell carcinomas from Taiwan. J Oral Pathol Med 1998;27:243-8.
el-Naggar AK, Lai S, Luna MA, Zhou XD, Weber RS, Goepfert H, et al.
Sequential p53 mutation analysis of pre-invasive and invasive head and neck squamous carcinoma. Int J Cancer 1995;64:196-201.
Lin HP, Wang YP, Chiang CP. Expression of p53, MDM2, p21, heat shock protein 70, and HPV 16/18 E6 proteins in oral verrucous carcinoma and oral verrucous hyperplasia. Head Neck 2011;33:334-40.
Wang YP, Chen HM, Kuo RC, Yu CH, Sun A, Liu BY, et al.
Oral verrucous hyperplasia: Histologic classification, prognosis, and clinical implications. J Oral Pathol Med 2009;38:651-6.
Murrah VA, Batsakis JG. Proliferative verrucous leukoplakia and verrucous hyperplasia. Ann Otol Rhinol Laryngol 1994;103(8 Pt 1):660-3.
Walvekar RR, Chaukar DA, Deshpande MS, Pai PS, Chaturvedi P, Kakade A, et al.
Verrucous carcinoma of the oral cavity: A clinical and pathological study of 101 cases. Oral Oncol 2009;45:47-51.
Ghazali N, Bakri MM, Zain RB. Aggressive, multifocal oral verrucous leukoplakia: Proliferative verrucous leukoplakia or not? J Oral Pathol Med 2003;32:383-92.
Bagan JV, Jimenez Y, Sanchis JM, Poveda R, Milian MA, Murillo J, et al.
Proliferative verrucous leukoplakia: High incidence of gingival squamous cell carcinoma. J Oral Pathol Med 2003;32:379-82.
Batsakis JG, Suarez P, el-Naggar AK. Proliferative verrucous leukoplakia and its related lesions. Oral Oncol 1999;35:354-9.
Klieb HB, Raphael SJ. Comparative study of the expression of p53, Ki67, E-cadherin and MMP-1 in verrucous hyperplasia and verrucous carcinoma of the oral cavity. Head Neck Pathol 2007;1:118-22.
Chang KW, Lin SC, Kwan PC, Wong YK. Association of aberrant p53 and p21(WAF1) immunoreactivity with the outcome of oral verrucous leukoplakia in Taiwan. J Oral Pathol Med 2000;29:56-62.
Neville BW, Damm DD, Allen CM, Bouquot JE. Oral & Maxillofacial Pathology. 2 nd
ed. Philadelphia: WB : Saunders; 2002. p. 368.
[Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5], [Figure 6]
[Table 1], [Table 2], [Table 3]